Defining Reference Ranges for Serum Anti-Müllerian Hormone on a Large Cohort of Normozoospermic Adult Men Highlights New Potential Physiological Functions of AMH on FSH Secretion and Sperm Motility.


Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
16 06 2022
Historique:
received: 17 01 2022
pubmed: 10 4 2022
medline: 22 6 2022
entrez: 9 4 2022
Statut: ppublish

Résumé

Few studies to date have attempted to measure serum anti-Müllerian hormone (AMH) levels in adult men, and solid references ranges have not yet been defined in a large cohort. In this study, we aimed, first, to establish the reference ranges for serum AMH and AMH-to-total testosterone ratio (AMH/tT) in adult males. Second, we investigated the relationship between serum AMH and both reproductive hormones and semen parameters. This single-center retrospective study included 578 normozoospermic adult men. Serum AMH concentrations were determined with an automated sandwich chemiluminescent immunoassay. The median serum AMH was 43.5 pmol/L. The 2.5th and 97.5th percentile values for serum AMH and AMH/tT were 16.4 and 90.3 pmol/L and 0.45 and 3.43, respectively. AMH was positively correlated with inhibin B and sperm concentration and negatively correlated with age, follicle-stimulating hormone (FSH), and progressive sperm motility. Interestingly, using immunofluorescence, we documented for the first time that AMH type II receptor (AMH-R2) is expressed in ejaculated human spermatozoa and gonadotrophic cells in the postmortem pituitary gland. We establish a new age-specific reference range for serum AMH and AMH/tT. Moreover, AMH-R2 expression in human spermatozoa and gonadotrophic cells, together with the relationship between serum AMH levels and sperm motility or mean FSH levels, highlight new potential functions of AMH in regulating sperm motility or FSH secretion in adult men.

Sections du résumé

BACKGROUND
Few studies to date have attempted to measure serum anti-Müllerian hormone (AMH) levels in adult men, and solid references ranges have not yet been defined in a large cohort.
OBJECTIVE
In this study, we aimed, first, to establish the reference ranges for serum AMH and AMH-to-total testosterone ratio (AMH/tT) in adult males. Second, we investigated the relationship between serum AMH and both reproductive hormones and semen parameters.
METHODS
This single-center retrospective study included 578 normozoospermic adult men. Serum AMH concentrations were determined with an automated sandwich chemiluminescent immunoassay.
RESULTS
The median serum AMH was 43.5 pmol/L. The 2.5th and 97.5th percentile values for serum AMH and AMH/tT were 16.4 and 90.3 pmol/L and 0.45 and 3.43, respectively. AMH was positively correlated with inhibin B and sperm concentration and negatively correlated with age, follicle-stimulating hormone (FSH), and progressive sperm motility. Interestingly, using immunofluorescence, we documented for the first time that AMH type II receptor (AMH-R2) is expressed in ejaculated human spermatozoa and gonadotrophic cells in the postmortem pituitary gland.
CONCLUSIONS
We establish a new age-specific reference range for serum AMH and AMH/tT. Moreover, AMH-R2 expression in human spermatozoa and gonadotrophic cells, together with the relationship between serum AMH levels and sperm motility or mean FSH levels, highlight new potential functions of AMH in regulating sperm motility or FSH secretion in adult men.

Identifiants

pubmed: 35396994
pii: 6565878
doi: 10.1210/clinem/dgac218
pmc: PMC9202722
doi:

Substances chimiques

Inhibins 57285-09-3
Anti-Mullerian Hormone 80497-65-0
Follicle Stimulating Hormone 9002-68-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1878-1887

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society.

Références

Andrology. 2014 Nov;2(6):918-23
pubmed: 25269872
Hum Reprod. 1999 Aug;14(8):2020-4
pubmed: 10438420
Clin Chim Acta. 2021 Oct;521:64-69
pubmed: 34181890
Nat Commun. 2016 Jan 12;7:10055
pubmed: 26753790
Endocrinology. 1995 Dec;136(12):5614-22
pubmed: 7588316
Genes Dev. 1996 Oct 15;10(20):2577-87
pubmed: 8895659
Fertil Steril. 2009 May;91(5):1812-9
pubmed: 18423454
Fertil Steril. 2007 Aug;88(2):516-8
pubmed: 17462637
Biol Reprod. 2017 Oct 1;97(4):522-536
pubmed: 29024992
Reprod Biomed Online. 2007 Feb;14(2):159-65
pubmed: 17298717
Innovation (Camb). 2021 Feb 09;2(1):100091
pubmed: 34557745
Andrology. 2018 Mar;6(2):286-292
pubmed: 29266868
Endocr Rev. 2019 Apr 1;40(2):669-710
pubmed: 30698671
Asian J Androl. 2007 Mar;9(2):265-70
pubmed: 17334594
J Clin Endocrinol Metab. 2009 May;94(5):1818-25
pubmed: 19276236
Sci Rep. 2017 Dec 15;7(1):17638
pubmed: 29247212
Eur J Endocrinol. 2015 Jun;172(6):669-76
pubmed: 25740852
Clin Endocrinol (Oxf). 2005 Sep;63(3):267-73
pubmed: 16117813
J Assist Reprod Genet. 2015 Nov;32(11):1691-6
pubmed: 26466940
J Clin Endocrinol Metab. 2010 Dec;95(12):5357-64
pubmed: 20843948
Cell. 2003 Jun 13;113(6):685-700
pubmed: 12809600
J Androl. 1998 Sep-Oct;19(5):568-72
pubmed: 9796616
Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9348-53
pubmed: 12878721
J Endocrinol. 1993 Aug;138(2):345-9
pubmed: 8228742
Trends Endocrinol Metab. 2003 Mar;14(2):91-7
pubmed: 12591180
Basic Clin Androl. 2021 Jun 17;31(1):15
pubmed: 34134632
J Clin Endocrinol Metab. 2019 Dec 1;104(12):6049-6059
pubmed: 31415086
Hum Reprod. 2016 Aug;31(8):1662-7
pubmed: 27220981
BMC Bioinformatics. 2006 Mar 09;7:123
pubmed: 16526949
Best Pract Res Clin Endocrinol Metab. 2010 Apr;24(2):263-77
pubmed: 20541151
PLoS One. 2015 Jul 20;10(7):e0133637
pubmed: 26192622
J Clin Endocrinol Metab. 2022 Jun 16;107(7):1878-1887
pubmed: 35396994
Neuroendocrinology. 2019;109(3):218-229
pubmed: 31280262
Sex Dev. 2017;11(3):109-125
pubmed: 28528332
Mol Endocrinol. 1994 Aug;8(8):1006-20
pubmed: 7997230
Sci Rep. 2016 Mar 31;6:23790
pubmed: 27030385
EJIFCC. 2008 Oct 16;19(2):95-105
pubmed: 27683304
J Clin Endocrinol Metab. 2018 May 1;103(5):1715-1744
pubmed: 29562364
Hum Reprod. 2012 Oct;27(10):3085-91
pubmed: 22777530
J Immunol Methods. 2010 Oct 31;362(1-2):51-9
pubmed: 20801125
Gynecol Endocrinol. 2011 Jun;27(6):401-5
pubmed: 20569102

Auteurs

Hamza Benderradji (H)

Department of Andrology, Urology and Renal Transplantation, University of Lille, CHU Lille, Lille, France.
Lille Neuroscience & Cognition (UMR-S1172), CHU Lille, Inserm, University of Lille, Lille, France.

Anne-Laure Barbotin (AL)

Lille Neuroscience & Cognition (UMR-S1172), CHU Lille, Inserm, University of Lille, Lille, France.
Department of Reproductive Biology-Spermiology-CECOS, University of Lille, CHU Lille, Lille, France.

Maryse Leroy-Billiard (M)

Department of Endocrine Gynecology and Reproductive Medicine, University of Lille, CHU Lille, Lille, France.

Julie Prasivoravong (J)

Department of Andrology, Urology and Renal Transplantation, University of Lille, CHU Lille, Lille, France.

François Marcelli (F)

Department of Andrology, Urology and Renal Transplantation, University of Lille, CHU Lille, Lille, France.

Christine Decanter (C)

Department of Endocrine Gynecology and Reproductive Medicine, University of Lille, CHU Lille, Lille, France.

Geoffroy Robin (G)

Department of Andrology, Urology and Renal Transplantation, University of Lille, CHU Lille, Lille, France.
Department of Endocrine Gynecology and Reproductive Medicine, University of Lille, CHU Lille, Lille, France.

Valérie Mitchell (V)

Lille Neuroscience & Cognition (UMR-S1172), CHU Lille, Inserm, University of Lille, Lille, France.
Department of Reproductive Biology-Spermiology-CECOS, University of Lille, CHU Lille, Lille, France.

Jean-Marc Rigot (JM)

Department of Andrology, Urology and Renal Transplantation, University of Lille, CHU Lille, Lille, France.

Antonino Bongiovanni (A)

University of Lille, Institut Pasteur de Lille, BioImaging Center Lille, Lille, France.

Florent Sauve (F)

Lille Neuroscience & Cognition (UMR-S1172), CHU Lille, Inserm, University of Lille, Lille, France.

Luc Buée (L)

Lille Neuroscience & Cognition (UMR-S1172), CHU Lille, Inserm, University of Lille, Lille, France.

Claude-Alain Maurage (CA)

Lille Neuroscience & Cognition (UMR-S1172), CHU Lille, Inserm, University of Lille, Lille, France.
University of Lille, CHU Lille, Department of Pathological Anatomy, Lille, France.

Maryse Cartigny (M)

Department of Pediatric Endocrinology, DevGen, Reference Centre for Genital Development Abnormalities, University of Lille, CHU Lille, Lille, France.

Arnauld Villers (A)

Department of Andrology, Urology and Renal Transplantation, University of Lille, CHU Lille, Lille, France.

Vincent Prevot (V)

Lille Neuroscience & Cognition (UMR-S1172), CHU Lille, Inserm, University of Lille, Lille, France.

Sophie Catteau-Jonard (S)

Lille Neuroscience & Cognition (UMR-S1172), CHU Lille, Inserm, University of Lille, Lille, France.
Department of Endocrine Gynecology and Reproductive Medicine, University of Lille, CHU Lille, Lille, France.

Nicolas Sergeant (N)

Lille Neuroscience & Cognition (UMR-S1172), CHU Lille, Inserm, University of Lille, Lille, France.

Paolo Giacobini (P)

Lille Neuroscience & Cognition (UMR-S1172), CHU Lille, Inserm, University of Lille, Lille, France.

Pascal Pigny (P)

Department of Biochemistry & Hormonology, CHU Lille, Lille, France.
University of Lille, Inserm, UMR-S 1277, Lille, France.

Clara Leroy (C)

Department of Andrology, Urology and Renal Transplantation, University of Lille, CHU Lille, Lille, France.
Department of Pediatric Endocrinology, DevGen, Reference Centre for Genital Development Abnormalities, University of Lille, CHU Lille, Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH